Litigation

Recent Posts

Burg Simpson Leads National Litigation Against DePuy Orthopaedics
Posted on 2 Feb 2011 by LexisNexis Litigation Resource Community Staff

DENVER - Burg Simpson Eldredge Hersh & Jardine P.C., one of the nation's leading plaintiff litigation law firms, has announced that shareholder Seth. A. Katz has been appointed by Judge David A. Katz to serve as a member of the Plaintiffs'... Read More

2nd Circuit Reject Overpromotion Exception To Learned Intermediary In Zyprexa Case
Posted on 16 Jul 2010 by Tom Moylan

NEW YORK - (Mealey's) A Second Circuit U.S. Court of Appeals panel on July 16 ruled that a Zyprexa multidistrict litigation plaintiff failed to show that alleged overpromotion of the atypical antipsychotic drug by manufacturer Eli Lilly and Co. misled... Read More

2nd Circuit Affirms Injunction Against Lawyer Who Disclosed Zyprexa MDL Documents
Posted on 12 Aug 2010 by Tom Moylan

NEW YORK - (Mealey's) The Zyprexa multidistrict litigation court properly enjoined an Alaska attorney and mental health advocate from obtaining and disseminating confidential discovery documents produced by Eli Lilly and Co., a panel of the Second... Read More

N.J. Risperdal Jury Finds Diabetes Warning Lacking, But Drug Didn't Cause Disease
Posted on 17 Feb 2012 by Tom Moylan

NEW BRUNSWICK, N.J. - (Mealey's) A Risperdal personal injury trial ended Feb. 16 in a defense verdict for Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc. after a New Jersey state court jury found that Janssen failed to warn about the... Read More

AstraZeneca Pays States $68.5M For Off-Label Marketing Of Seroquel Antipsychotic
Posted on 11 Mar 2011 by Tom Moylan

TRENTON, N.J. - (Mealey's) AstraZeneca Pharmaceuticals L.P. and AstraZeneca L.P. on March 10 agreed to pay $68.5 million to 37 states and the District of Columbia to resolve allegations in a New Jersey state court lawsuit that it marketed its atypical... Read More

6 Third-Party Payers Settle Zyprexa Claims For $4.5Million After Class Vacated
Posted on 13 Jan 2012 by Tom Moylan

BROOKLYN, N.Y. - (Mealey's) The Zyprexa multidistrict litigation judge on Jan. 12 approved a $4.5 million settlement between Eli Lilly and Co. and six third-party payers who had their Racketeer Influence and Corrupt Organizations Act (RICO) class... Read More